GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (NYSE:STE) » Definitions » Cyclically Adjusted PS Ratio

Steris (Steris) Cyclically Adjusted PS Ratio : 4.75 (As of May. 02, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Steris Cyclically Adjusted PS Ratio?

As of today (2024-05-02), Steris's current share price is $206.24. Steris's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $43.38. Steris's Cyclically Adjusted PS Ratio for today is 4.75.

The historical rank and industry rank for Steris's Cyclically Adjusted PS Ratio or its related term are showing as below:

STE' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.85   Med: 3.95   Max: 6.86
Current: 4.73

During the past years, Steris's highest Cyclically Adjusted PS Ratio was 6.86. The lowest was 1.85. And the median was 3.95.

STE's Cyclically Adjusted PS Ratio is ranked worse than
68.71% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs STE: 4.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Steris's adjusted revenue per share data for the three months ended in Dec. 2023 was $14.047. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $43.38 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Steris Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Steris's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Cyclically Adjusted PS Ratio Chart

Steris Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 4.52 5.76 6.42 4.64

Steris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.61 4.64 5.34 5.10 5.07

Competitive Comparison of Steris's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Steris's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Steris's Cyclically Adjusted PS Ratio falls into.



Steris Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Steris's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=206.24/43.38
=4.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Steris's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=14.047/129.4194*129.4194
=14.047

Current CPI (Dec. 2023) = 129.4194.

Steris Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 7.788 99.695 10.110
201406 6.899 100.560 8.879
201409 7.710 100.428 9.936
201412 7.868 99.070 10.278
201503 8.333 99.621 10.826
201506 7.297 100.684 9.380
201509 8.115 100.392 10.461
201512 7.961 99.792 10.325
201603 7.992 100.470 10.295
201606 7.378 101.688 9.390
201609 7.487 101.861 9.513
201612 7.562 101.863 9.608
201703 7.921 102.862 9.966
201706 7.092 103.349 8.881
201709 7.385 104.136 9.178
201712 7.722 104.011 9.608
201803 8.370 105.290 10.288
201806 7.470 106.317 9.093
201809 7.943 106.507 9.652
201812 8.149 105.998 9.950
201903 8.991 107.251 10.849
201906 8.143 108.070 9.752
201909 8.598 108.329 10.272
201912 9.042 108.420 10.793
202003 9.606 108.902 11.416
202006 7.808 108.767 9.291
202009 8.808 109.815 10.380
202012 9.403 109.897 11.073
202103 10.153 111.754 11.758
202106 10.643 114.631 12.016
202109 11.888 115.734 13.294
202112 11.991 117.630 13.193
202203 12.011 121.301 12.815
202206 11.482 125.017 11.886
202209 12.009 125.227 12.411
202212 12.140 125.222 12.547
202303 13.682 127.348 13.905
202306 12.944 128.729 13.013
202309 13.504 129.860 13.458
202312 14.047 129.419 14.047

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Steris  (NYSE:STE) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Steris Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Steris's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Steris (Steris) Business Description

Traded in Other Exchanges
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Executives
Richard C Breeden director 100 SOUTH WACKER, SUITE 1800, CHICAGO IL 60606
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Jacqueline B Kosecoff director 5960 HEISLEY ROAD, MENTOR OH 44060
Mohsen Sohi director C/O STERIS CORPORATION, 5960 HEISLEY ROAD, MENTOR OH 44060
Esther M. Alegria director 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780
Cary L Majors officer: VP, N America Com Operations 5960 HEISLEY ROAD, MENTOR OH 44060
John Adam Zangerle director, officer: Sr. VP, Gen Counsel, and Sec. 5960 HEISLEY ROAD, MENTOR OH 44060
Michael J Tokich director, officer: Sr. Vice Pres., CFO C/O STERIS CORP, 5960 HEISLEY RD, MENTOR OH 44060
Karen L Burton officer: VP, Controller & CAO 5960 HEISLEY ROAD, MENTOR OH 44060
Renato Tamaro officer: V.P. & Corporate Treasurer 5960 HEISLEY ROAD, MENTOR OH 44060
Andrew Xilas officer: SVP and GM, Dental 5960 HEISLEY ROAD, MENTOR OH 44060
Paul Edward Martin director C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, SUITE 100, BLUE BELL PA 19422
Julia Madsen officer: Senior VP, Life Sciences 5960 HEISLEY ROAD, MENTOR OH 44060
David B Lewis director
Rosebrough Walter M Jr officer: President & CEO 5960 HEISLEY ROAD, MENTOR OH 44060